Shelter Pharma Ltd
Incorporated in 2007, Shelter Pharma Ltd manufactures pharma products including
food supplements for animals[1]
- Market Cap ₹ 70.9 Cr.
- Current Price ₹ 61.4
- High / Low ₹ 80.9 / 41.1
- Stock P/E 10.6
- Book Value ₹ 34.0
- Dividend Yield 0.54 %
- ROCE 32.8 %
- ROE 25.0 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 31.9%
Cons
- Promoter holding has decreased over last quarter: -1.92%
- Debtor days have increased from 61.0 to 80.9 days.
- Working capital days have increased from 140 days to 212 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|
28.09 | 29.95 | 30.07 | 22.48 | 30.06 | 36.15 | 39.93 | 44.77 | |
27.94 | 30.65 | 29.83 | 22.29 | 27.01 | 28.00 | 31.02 | 35.58 | |
Operating Profit | 0.15 | -0.70 | 0.24 | 0.19 | 3.05 | 8.15 | 8.91 | 9.19 |
OPM % | 0.53% | -2.34% | 0.80% | 0.85% | 10.15% | 22.54% | 22.31% | 20.53% |
0.00 | 0.83 | 0.01 | 0.01 | 0.00 | -0.97 | -0.12 | 0.00 | |
Interest | 0.00 | 0.00 | 0.01 | 0.02 | 0.08 | 0.03 | 0.26 | 0.07 |
Depreciation | 0.10 | 0.07 | 0.13 | 0.12 | 0.17 | 0.16 | 0.25 | 0.23 |
Profit before tax | 0.05 | 0.06 | 0.11 | 0.06 | 2.80 | 6.99 | 8.28 | 8.89 |
Tax % | 20.00% | 16.67% | 27.27% | 33.33% | 26.79% | 25.46% | 25.12% | |
0.05 | 0.05 | 0.08 | 0.04 | 2.06 | 5.21 | 6.20 | 6.66 | |
EPS in Rs | 1.10 | 1.10 | 1.76 | 0.83 | 42.56 | 6.73 | 5.36 | 5.76 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 21% |
TTM: | 16% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 440% |
TTM: | 7% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -3% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 32% |
Last Year: | 25% |
Balance Sheet
Figures in Rs. Crores
Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 0.45 | 0.45 | 0.45 | 0.48 | 0.48 | 7.74 | 11.56 | 11.56 |
Reserves | 7.31 | 7.32 | 6.53 | 6.63 | 8.32 | 6.81 | 24.26 | 27.76 |
2.07 | 0.11 | 0.24 | 0.00 | 0.13 | 1.78 | 0.57 | 1.11 | |
1.73 | 3.76 | 3.41 | 3.09 | 3.91 | 5.12 | 1.52 | 2.55 | |
Total Liabilities | 11.56 | 11.64 | 10.63 | 10.20 | 12.84 | 21.45 | 37.91 | 42.98 |
2.61 | 2.71 | 1.77 | 1.57 | 1.45 | 2.52 | 4.26 | 4.37 | |
CWIP | 0.14 | 0.11 | 0.00 | 0.00 | 0.55 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.68 | 0.68 | 0.68 | 0.00 | 0.00 | 0.68 |
8.81 | 8.82 | 8.18 | 7.95 | 10.16 | 18.93 | 33.65 | 37.93 | |
Total Assets | 11.56 | 11.64 | 10.63 | 10.20 | 12.84 | 21.45 | 37.91 | 42.98 |
Cash Flows
Figures in Rs. Crores
Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
0.00 | -0.27 | -0.28 | 0.52 | 0.00 | -1.85 | ||
0.00 | 0.29 | 0.03 | -0.85 | 0.11 | -4.54 | ||
0.00 | 0.00 | 0.48 | 0.06 | 0.21 | 11.01 | ||
Net Cash Flow | 0.00 | 0.02 | 0.23 | -0.27 | 0.33 | 4.61 |
Ratios
Figures in Rs. Crores
Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
Debtor Days | 12.99 | 14.14 | 7.40 | 12.34 | 19.55 | 82.69 | 80.90 |
Inventory Days | 61.39 | 49.67 | 55.59 | 69.41 | 80.06 | 110.68 | 125.33 |
Days Payable | 2.49 | 2.16 | 3.35 | 5.35 | 4.52 | 6.54 | 8.96 |
Cash Conversion Cycle | 71.89 | 61.65 | 59.64 | 76.40 | 95.09 | 186.84 | 197.26 |
Working Capital Days | 91.35 | 59.59 | 57.05 | 74.85 | 72.49 | 134.69 | 212.07 |
ROCE % | 0.68% | 1.12% | 35.91% | 63.26% | 32.85% |
Documents
Announcements
-
Closure of Trading Window
2d - Board meeting to consider equity share fund raising.
-
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To The SEBI (LODR) Regulations, 2015 ('SEBI Listing Regulations').
2d - Board meeting to consider equity share fund raising.
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
26 Dec - Shelter Pharma secured a $23,000 order from FIRSTVET.
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
14 Nov 2024 - Resignation of Company Secretary effective November 13, 2024.
-
Non-Applicability Of Regulation 23(9) As Per Regulation 15 Of Chapter IV Of SEBI (LODR) Regulations, 2015 For The Half Year And Year Ended September 2024
30 Oct 2024 - Non-applicability of Regulation 23(9) for half year.
Business Overview:[1]
SPL is a GMP & HACCP certified and ISO 9001:2015 certified manufacturer and seller of a range of herbal Ayurvedic medicines in India for humans and food supplements for animals